Rationale and design of the TRICHAMPION trial: Triple Chamber Pacing in Hypertrophic Obstructive Cardiomyopathy Patients

[1]  J. Brugada,et al.  Optimized pacing mode for hypertrophic cardiomyopathy: Impact of ECG fusion during pacing. , 2015, Heart rhythm.

[2]  F. Rutten,et al.  2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). , 2014, European heart journal.

[3]  Lluís Mont,et al.  2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). , 2013, European heart journal.

[4]  B. Firwana,et al.  Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy. , 2012, The Cochrane database of systematic reviews.

[5]  J. Brugada,et al.  Biventricular pacing in hypertrophic obstructive cardiomyopathy: a pilot study. , 2011, Heart rhythm.

[6]  N. Smedira,et al.  Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy. , 2010, Journal of the American College of Cardiology.

[7]  A. Tajik,et al.  Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy. , 2007, European heart journal.

[8]  J. Daubert,et al.  Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. , 2007, European heart journal.

[9]  K. Jacek,et al.  Resynchronization or Dyssynchronization—Successful Treatment with Biventricular Stimulation of a Child with Obstructive Hypertrophic Cardiomyopathy without Dyssynchrony , 2007 .

[10]  R. Lenarczyk,et al.  Resynchronization or dyssynchronization--successful treatment with biventricular stimulation of a child with obstructive hypertrophic cardiomyopathy without dyssynchrony. , 2007, Journal of cardiovascular electrophysiology.

[11]  P. Elliott,et al.  Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy. , 2006, European heart journal.

[12]  D. Ural,et al.  Effect of Biventricular Pacing on Left Ventricular Outflow Tract Pressure Gradient in a Patient with Hypertrophic Cardiomyopathy and Normal Interventricular Conduction , 2006, Journal of cardiovascular electrophysiology.

[13]  Y. Kitaura,et al.  Usefulness of tissue Doppler imaging for demonstrating altered septal contraction sequence during dual-chamber pacing in obstructive hypertrophic cardiomyopathy. , 2005, The American journal of cardiology.

[14]  A. Tajik,et al.  Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. , 2005, Journal of the American College of Cardiology.

[15]  T. Tsuchiya,et al.  Impact of right atrial-left ventricular dual-chamber permanent pacing in patients with severely symptomatic hypertrophic obstructive cardiomyopathy. , 2005, Circulation journal : official journal of the Japanese Circulation Society.

[16]  H. Yoshimatsu,et al.  Improved hypertrophic obstructive cardiomyopathy by left ventricular apex epicardial pacing. , 2004, Internal medicine.

[17]  R. Hui,et al.  Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults. , 2004, The American journal of medicine.

[18]  B. Maron.  Hypertrophic cardiomyopathy: an important global disease. , 2004, The American journal of medicine.

[19]  B. Maron,et al.  Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. , 2003, The New England journal of medicine.

[20]  C. Rinaldi,et al.  Beneficial effects of biventricular pacing in a patient with hypertrophic cardiomyopathy and intraventricular conduction delay , 2002, Heart.

[21]  M. Sherrid,et al.  Systolic anterior motion begins at low left ventricular outflow tract velocity in obstructive hypertrophic cardiomyopathy. , 2000, Journal of the American College of Cardiology.

[22]  M. Josephson,et al.  Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY). , 1999, Circulation.

[23]  W. Mckenna,et al.  Clinical progress after randomized on/off pacemaker treatment for hypertrophic obstructive cardiomyopathy. Pacing in Cardiomyopathy (PIC) Study Group. , 1999, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[24]  L. Rydén,et al.  Placebo effect of pacemaker implantation in obstructive hypertrophic cardiomyopathy. PIC Study Group. Pacing In Cardiomyopathy. , 1999, The American journal of cardiology.

[25]  M. Griffith,et al.  Ablation of the atrioventricular junction: technique, acute and long-term results in 115 consecutive patients. , 1999, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[26]  M. Sherrid,et al.  Mechanism of benefit of negative inotropes in obstructive hypertrophic cardiomyopathy. , 1998, Circulation.

[27]  F. Gadler,et al.  Modification of atrioventricular conduction as adjunct therapy for pacemaker-treated patients with hypertrophic obstructive cardiomyopathy. , 1998, European heart journal.

[28]  D. Kass,et al.  Mechanism of acute mechanical benefit from VDD pacing in hypertrophied heart: similarity of responses in hypertrophic cardiomyopathy and hypertensive heart disease. , 1998, Circulation.

[29]  W. Mckenna,et al.  Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. PIC Study Group. , 1997, European heart journal.

[30]  L. Rydén,et al.  Long-term effects of dual chamber pacing in patients with hypertrophic cardiomyopathy without outflow tract obstruction at rest. , 1997, European heart journal.

[31]  J. Schläpfer,et al.  Dual Chamber Pacing in Hypertrophic Obstructive Cardiomyopathy: Beneficial Effect of Atrioventricular Junction Ablation for Optimal Left Ventricular Capture and Filling , 1997, Pacing and clinical electrophysiology : PACE.

[32]  A. Tajik,et al.  Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial. , 1997, Journal of the American College of Cardiology.

[33]  L. Rydén,et al.  Influence of right ventricular pacing site on left ventricular outflow tract obstruction in patients with hypertrophic obstructive cardiomyopathy. , 1996, Journal of the American College of Cardiology.

[34]  A. Camm,et al.  DDD pacing in hypertrophic cardiomyopathy: a multicentre clinical experience. , 1996, Heart.

[35]  J. Gardin,et al.  Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. , 1995, Circulation.

[36]  D Tripodi,et al.  Long‐term Results of Dual‐Chamber (DDD) Pacing in Obstructive Hypertrophic Cardiomyopathy: Evidence for Progressive Symptomatic and Hemodynamic Improvement and Reduction of Left Ventricular Hypertrophy , 1994, Circulation.